Browsing by Author "Güner, Rahmet"
Now showing items 1-2 of 2
-
The Role of Pneumococcal Pneumonia among CommunityAcquired Pneumonia in Adult Turkish Population: TurkCAP Study
Şenol, Esin; Çilli, Aykut; Günen, Hakan; Şener, Alper; Dumlu, Rıdvan; Ödemiş, Ayşe; Topçu, Ayşe Füsun; Yıldız, Yeşim; Güner, Rahmet; Özhasenekler, Ayhan; Mutlu, Birsen; Köktürk, Nurdan; Sevimli, Nurgül; Baykam, Nurcan; Yapar, Derya; Ekin, Selami; Polatlı, Mehmet; Eren Gök, Şebnem; Kılınç, Oğuz; Sayıner, Abdullah; Karaşahin, Ömer; Çuhadaroğlu, Çağlar; Sesin Kocagöz, Ayşe; Togan, Turhan; Arpağ, Hüseyin; Katı, Hakan; Köksal, İftihar; Aksoy, Firdevs; Hasanoğlu, Canan (AVES, 2021)OBJECTIVE: To evaluate the rate of pneumococcal pneumonia (PP) among patients with community-acquired pneumonia (CAP) in Turkey and to investigate and compare features of PP and non-PP CAP patients. MATERIAL AND METHODS: ... -
Switching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkey
Tabak, Fehmi; Yörük, Gülşen; Köksal, İftihar; Erdem, Hazal; Yıldız, Dilek; İnce, Nevin; Yamazhan, Tansu; Sume, Serkan; Batırel, Ayşe; Günal, Özgür; Yıldız, İlknur Esen; Sırmatel, Fatma; Koç, Meliha Merih; Çeken, Sabahat; Bozkurt, İlkay; Görenek, Levent; Şener, Alper; Köse, Şükran; Türker, Kamuran; İnan, Dilara; Karabay, Oğuz; Güner, Rahmet (Wiley, 2021)Tenofovir alafenamide (TAF) is a new prodrug of tenofovir used for the treatment of HIV-1 and HBV infections. It provides more efficient intracellular tenofovir concentrations at a relatively lower dose than provided by ...
